Solasto Corp
TSE:6197
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (13.8), the stock would be worth ¥304.95 (73% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 50.6 | ¥1 119 |
0%
|
| 3-Year Average | 13.8 | ¥304.95 |
-73%
|
| 5-Year Average | 13.8 | ¥305.43 |
-73%
|
| Industry Average | 31.8 | ¥704.7 |
-37%
|
| Country Average | 22.4 | ¥494.75 |
-56%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Solasto Corp
TSE:6197
|
101.8B JPY | 50.6 | 24 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
104.3B USD | 12.3 | 59 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 12.6 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.5B USD | 0 | 12.5 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | -25.1 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 13.9 | 22.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.4B USD | 23.7 | 21 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21B USD | 627.8 | 24 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 6.7 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 69.1 | -27.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 6 | 13.9 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 14.9 |
| Median | 22.4 |
| 70th Percentile | 35 |
| Max | 736 044 589.7 |
Other Multiples
Solasto Corp
Glance View
Solasto Corp. engages in the provision of medical and welfare-related services. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 29,838 full-time employees. The company went IPO on 2016-06-29. The firm has two business segments. The Medical Related Contract segment is engaged in the provision of contract and staffing services such as reception, accounting, medical fee billing, hospital management support and other medical office related services. The Nursing Care And Childcare segment is engaged in the provision of home help services, day services, paid nursing homes with long-term care services, care houses, residential-type paid elderly homes, home care support services, group homes, home-visit nursing care services, childcare services, as well as the rental and sale of welfare equipment. The firm is also engaged in the provision of education and training services such as medical and nursing care related courses, the skill certification test business, the real estate leasing business, and the insurance agency business.
